Caeli Vascular, Inc.

Caeli Vascular has developed a proprietary catheter-based modular multi-modal technology platform for treating venous obstructive disease along the entire disease continuum from early acute through chronic stages. Chronic disease, in particular, remains a significant unmet need afflicting over 250,000 patients in the U.S. annually and is a significant financial burden on the healthcare system. Caeli's system provides infusion, clot fragmentation, and aspiration all within a confined treatment zone that minimizes embolization, bleeding, and blood loss during aspiration. With its multimodal closed system design, the Caeli Vascular SPECTRUM system improves outcomes, enhances safety margins, and reduces costs.

• Employees7
• Founded2019